Hetaryl imidazoles: A novel dual inhibitors of VEGF receptors I and II
- 1 March 2006
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (5) , 1440-1444
Abstract
No abstract availableKeywords
This publication has 16 references indexed in Scilit:
- Synthesis and structure–activity relationships of 1,2,4-triazoles as a novel class of potent tubulin polymerization inhibitorsBioorganic & Medicinal Chemistry Letters, 2005
- Arylphthalazines: Identification of a new phthalazine chemotype as inhibitors of VEGFR kinaseBioorganic & Medicinal Chemistry Letters, 2005
- AZD2171: A Highly Potent, Orally Bioavailable, Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor for the Treatment of CancerCancer Research, 2005
- Pegaptanib sodiumNature Reviews Drug Discovery, 2005
- Bevacizumab: Antiangiogenic cancer therapyDrugs of Today, 2005
- Anthranilic Acid Amides: A Novel Class of Antiangiogenic VEGF Receptor Kinase InhibitorsJournal of Medicinal Chemistry, 2002
- Novel 4-Anilinoquinazolines with C-7 Basic Side Chains: Design and Structure Activity Relationship of a Series of Potent, Orally Active, VEGF Receptor Tyrosine Kinase InhibitorsJournal of Medicinal Chemistry, 2002
- New Anilinophthalazines as Potent and Orally Well Absorbed Inhibitors of the VEGF Receptor Tyrosine Kinases Useful as Antagonists of Tumor-Driven AngiogenesisJournal of Medicinal Chemistry, 2000
- Molecular angiogenesisChemistry & Biology, 1999
- Mechanisms of angiogenesisNature, 1997